Anal cancers among HIV-infected persons: HAART is not slowing rising incidence

AIDS

Volumn 24, Issue 4, 2010, Pages 535-543

  Crum Cianflone, Nancy F ^a,b   Hullsiek, Katherine Huppler ^c   Marconi, Vincent C ^a,d   Ganesan, Anuradha ^a,e   Weintrob, Amy ^a,e   Barthel, Robert V ^a,f   Agan, Brian K ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

Anal cancer; Antiretroviral therapy; Epidemiology; HAART; HIV; Incidence rates

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE DURATION; FOLLOW UP; GONORRHEA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MILITARY PERSONNEL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; UNITED STATES;

EID: 77649263071     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328331f6e2     Document Type: Article

References (32)

1. Patel P Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, et al. Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States 1992-2003. Ann Intern Med 2008 148 728-736.
2. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al., for the HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645-1654.
3. Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009; 23:41-50.
4. Palefsky J. Human papillomavirus and anal neoplasia. Curr HIV/ AIDS Rep 2008; 5:78-85.
5. Haga T, Kim SH, Jensen RH, Darragh T, Palefsky JM. Detection of genetic changes in anal intraepithelial neoplasia (AID) of HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr 2001; 26:256-262.
6. Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87:61-64.
7. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337:1350-1358.
8. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al., editors. SEER Cancer Statistics Review, 1975-2006 [based on November 2008 SEER data submission]. Bethesda, Maryland, USA: National Cancer Institute; 2009. http://seer.cancer.gov/csr/1975-2006/. [Accessed 15 March 2009].
9. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States. Am J Epidemiol 1994; 139:772-780.
10. D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008; 48:491-499.
11. Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarc-hand M, Abramowitz L, et al., FHDH-ANRS CO 4. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination anti-retroviral therapy. AIDS 2008; 22:1203-1211.
12. Diamond C, Taylor TH, Aboumrad T, Bringman D, Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005; 32:314-320.
13. Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005; 40:451-455.
14. Silverberg M, Leyden W, Chao C, Xu L, Tang B, Horberg M, et al. Infection-related non-AIDS-defining cancer risk in HIV-infected and-uninfected persons [abstract #30]. 16th Conference on Retroviruses and Opportunistic Infections; 8-11 February 2009; Montreal, Canada; 2009.
15. Centers for Disease Control (CDC). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41:961-962.
16. Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008; 113:2892-2900.
17. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372:293-299.
18. Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31:96-99.
19. Palefsky JM. Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection. J Acquir Immune Defic Syndr 1999; 21:S42-S48.
20. Palefsky JM, Holly EA, Efirdc JT, Da Costa M, Jay N, Berry JM, et al. Anal intraepithelial neoplasia in the highly active anti-retroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19:1407-1414.
21. Fagan SP, Bellows CF 3rd, Albo D, Rodriquez-Barradas M, Feanny M, Awad SS, et al. Length of human immunodeficiency virus disease and not immune status is a risk factor for development of anal carcinoma. Am J Surg 2005; 190:732-735.
22. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 1986; 58:611-616.
23. Abramowitz L, Benabderrahmane D, Ravaud P, Walker F, Rioux C, Jestin C, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007; 21:1457-1465.
24. Scott H, Khoury J, Moore BA, Weissman S. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis 2008; 35:197-202.
25. Chiao EY, Giordano TP, Richardson P, El-Serag HB. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol 2008; 26:474-479.
26. Wexler A, Berson AM, Goldstone SE, Waltzman R, Penzer J, Maisonet OG, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008; 51:73-81.
27. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006; 43:223-233.
28. Chin-Hong PV, Berry JM, Cheng SC, Catania JA, Da Costa M, Darragh TM, et al. Comparison of patient-and clinician-collected anal cytology samples to screen for human papilloma-virus-associated anal intraepithelial neoplasiain men who have sex with men. Ann Intern Med 2008; 149:300-306.
29. Karnon J, Jones R, Czoski-Murray C, Smith KJ. Cost-utility analysis of screening high-risk groups for anal cancer. J Public Health (Oxf) 2008; 30:293-304.
30. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281:1822-1829.
31. Massad LS, Seaberg EC, Watts DH, Minkoff H, Levine AM, Henry D, et al. Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer 2009; 115:524-530.
32. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, et al. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999; 131:502-506.